COST-EFFECTIVENESS ANALYSIS OF DAPTOMYCIN VERSUS VANCOMYCIN IN COMPLICATED SKIN AND SOFT STRUCTURE INFECTION (CSSSI) USING A DECISION ANALYTIC MODEL

被引：0
|
作者：
Zargarzadeh, A. [1 ]
Bounthavong, M. [2 ]
Hsu, D. [1 ]
Okamoto, M. P. [3 ]
机构：
[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
[2] VASDHS, San Diego, CA USA
[3] Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73620-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A111 / A112
页数：2
相关论文
共 50 条
  • [21] An explorative cost-effectiveness analysis of school-based screening for child anxiety using a decision analytic model
    Ellin Simon
    Carmen D. Dirksen
    Susan M. Bögels
    European Child & Adolescent Psychiatry, 2013, 22 : 619 - 630
  • [22] Cost-effectiveness study of CT colonography versus colonoscopy using decision analysis
    Heitman, S
    Fong, A
    Dean, S
    Hilsden, R
    Manns, B
    Romagnuolo, J
    GASTROENTEROLOGY, 2004, 126 (04) : A202 - A202
  • [23] COST COMPARISON OF LINEZOLID VERSUS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTION CAUSED BY MRSA IN QUEBEC
    Pettigrew, M.
    Thirion, D. J.
    Libman, M.
    Zanotti, G.
    VALUE IN HEALTH, 2011, 14 (03) : A116 - A116
  • [24] Cost-Effectiveness of Daptomycin versus Vancomycin and Gentamicin for Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and/or Endocarditis
    Bhavnani, S. M.
    Prakhya, A.
    Hammel, J. P.
    Ambrose, P. G.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 691 - 698
  • [25] COST-EFFECTIVENESS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION IN SPAIN
    Watt, M.
    de Nigris, E.
    McCrea, C.
    VALUE IN HEALTH, 2017, 20 (09) : A784 - A784
  • [26] A cost-effectiveness clinical decision analysis model for schizophrenia
    Palmer, CS
    Revicki, DA
    Genduso, LA
    Hamilton, SH
    Brown, RE
    AMERICAN JOURNAL OF MANAGED CARE, 1998, 4 (03): : 345 - 355
  • [27] COST-EFFECTIVENESS OF TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION: A DECISION-ANALYTIC MODEL
    Amin, Amit P.
    Marso, Steven P.
    Chhatriwalla, Adnan
    Safley, David
    Kennedy, Kevin
    House, John
    Mills, Rebecca
    Salisbury, Adam
    Spertus, John
    Cohen, David
    Baklanov, Dmitri
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E338 - E338
  • [28] Cost-effectiveness of abciximab after coronary stenting: A decision-analytic model
    Rodriguez, O
    Cutlip, DE
    Kuntz, RE
    Cohen, DJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 51A - 51A
  • [29] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    G. Feljandro P. Ramos
    Antoinette D. I. van Asselt
    Sandra Kuiper
    Johan L. Severens
    Tanja Maas
    Edward Dompeling
    J. André Knottnerus
    Onno C. P. van Schayck
    The European Journal of Health Economics, 2014, 15 : 869 - 883
  • [30] COST-EFFECTIVENESS OF ANTIMICROBIALS AS TREATMENT FOR PATIENTS WITH COMPLICATED SKIN AND SOFT TISSUES INFECTIONS: A COMPARISON BETWEEN CEFTAROLINE, LINEZOLID AND VANCOMYCIN IN THE RUSSIAN HEALTH CARE
    Kulikov, A.
    Komarov, I
    VALUE IN HEALTH, 2013, 16 (07) : A355 - A355
12345